Kazumasa Oya

26PUBLICATIONS
15CO-AUTHORS
PeriodonticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Apr 05, 2024
Perforating collagenosis.

Kazumasa Oya, Aki Saito

|Mar 04, 2024
Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies.

Kazumasa Oya, Yoshiyuki Nakamura, Larina Tzu-Wei Shen

|Oct 27, 2022
Plasma Exchange May Enhance Antitumor Effects by Removal of Soluble Programmed Death-Ligand 1 and Extracellular Vesicles: Preliminary Study.

Kazumasa Oya, Larina Tzu-Wei Shen, Kazushi Maruo

|Aug 27, 2021
Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect.

Kazumasa Oya, Yoshiyuki Nakamura, Zhu Zhenjie

Pageof 5

Frequent Collaborators

9 joint publications

Yasuhiro Fujisawa

8 joint publications

Yoshiyuki Nakamura

6 joint publications

Toshifumi Nomura

5 joint publications

Naoko Okiyama